• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子Xa和凝血酶对基质金属蛋白酶-2酶活性的调节机制

Regulatory mechanism of matrix metalloprotease-2 enzymatic activity by factor Xa and thrombin.

作者信息

Koo Bon-Hun, Park Michael Y, Jeon Ok-Hee, Kim Doo-Sik

机构信息

National Research Laboratory, Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, 134 Sinchon-Dong Seodaemun-Gu, Seoul 120-749, Korea.

出版信息

J Biol Chem. 2009 Aug 28;284(35):23375-85. doi: 10.1074/jbc.M109.036848. Epub 2009 Jul 6.

DOI:10.1074/jbc.M109.036848
PMID:19581306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2749111/
Abstract

Matrix metalloprotease (MMP)-2 plays a key role in many biological and pathological processes related to cell migration, invasion, and mitogenesis. MMP-2 is synthesized as a zymogen that is activated through either a conformational change or proteolysis of the propeptide. Several activating enzymes for pro-MMP-2 have been proposed, including metalloproteases and serine proteases. The mechanism of pro-MMP-2 activation by metalloproteases is well established, and the most studied activation mechanism involves cleavage of the propeptide by membrane type 1-MMP (MT1-MMP). In contrast, serine protease activation has not been thoroughly studied, although studies suggest that MT1-MMP may be involved in activation by thrombin and plasmin. Here, we demonstrate that factor Xa mediates MT1-MMP-independent processing of pro-MMP-2 in vascular smooth muscle cells and endothelial cells. Factor Xa and thrombin directly cleaved the propeptide on the carboxyl terminal sides of the Arg(98) and Arg(101) residues, whereas plasmin only cleaved the propeptide downstream of Arg(101). Moreover, processed MMP-2 showed enzymatic activity that was enhanced by intermolecular autoproteolytic processing at the Asn(109)-Tyr peptide bond. In addition to its role in activation, factor Xa rapidly degraded MMP-2, thereby restricting excessive MMP-2 activity. Thrombin also degraded MMP-2, but the degradation was reduced greatly under cell-associated conditions, resulting in an increase in processed MMP-2. Overall, factor Xa and thrombin regulate MMP-2 enzymatic activity through its activation and degradation. Thus, the net enzymatic activity results from a balance between MMP-2 activation and degradation.

摘要

基质金属蛋白酶(MMP)-2在许多与细胞迁移、侵袭和有丝分裂相关的生物学和病理过程中起关键作用。MMP-2以酶原形式合成,通过前肽的构象变化或蛋白水解作用被激活。已提出几种前MMP-2的激活酶,包括金属蛋白酶和丝氨酸蛋白酶。金属蛋白酶激活前MMP-2的机制已得到充分证实,研究最多的激活机制涉及膜型1-MMP(MT1-MMP)对前肽的切割。相比之下,丝氨酸蛋白酶激活机制尚未得到深入研究,尽管研究表明MT1-MMP可能参与凝血酶和纤溶酶的激活过程。在此,我们证明因子Xa在血管平滑肌细胞和内皮细胞中介导不依赖MT1-MMP的前MMP-2加工过程。因子Xa和凝血酶直接在精氨酸(98)和精氨酸(101)残基的羧基末端侧切割前肽,而纤溶酶仅在精氨酸(101)下游切割前肽。此外,加工后的MMP-2表现出酶活性,该活性通过在天冬酰胺(109)-酪氨酸肽键处的分子间自蛋白水解加工而增强。除了其在激活中的作用外,因子Xa还能快速降解MMP-2,从而限制MMP-2的过度活性。凝血酶也能降解MMP-2,但在细胞相关条件下,降解作用大大降低,导致加工后的MMP-2增加。总体而言,因子Xa和凝血酶通过激活和降解来调节MMP-2的酶活性。因此,净酶活性是MMP-2激活和降解之间平衡的结果。

相似文献

1
Regulatory mechanism of matrix metalloprotease-2 enzymatic activity by factor Xa and thrombin.凝血因子Xa和凝血酶对基质金属蛋白酶-2酶活性的调节机制
J Biol Chem. 2009 Aug 28;284(35):23375-85. doi: 10.1074/jbc.M109.036848. Epub 2009 Jul 6.
2
Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation.基质金属蛋白酶-2(MMP-2)的二聚化:对 MMP-2 激活的功能意义。
J Biol Chem. 2012 Jun 29;287(27):22643-53. doi: 10.1074/jbc.M111.337949. Epub 2012 May 10.
3
Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.凝血酶依赖性 MMP-2 活性受肝素硫酸酯调节。
J Biol Chem. 2010 Dec 31;285(53):41270-9. doi: 10.1074/jbc.M110.171595. Epub 2010 Nov 1.
4
Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase.糖基化拓宽了膜型1基质金属蛋白酶的底物谱。
J Biol Chem. 2004 Feb 27;279(9):8278-89. doi: 10.1074/jbc.M311870200. Epub 2003 Dec 11.
5
Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.红酒中的多酚类化合物通过直接抑制血管平滑肌细胞中的1型膜基质金属蛋白酶,强烈抑制凝血酶诱导的前基质金属蛋白酶-2的表达及其激活。
Circulation. 2004 Sep 28;110(13):1861-7. doi: 10.1161/01.CIR.0000142617.52881.F4. Epub 2004 Sep 13.
6
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.膜型1基质金属蛋白酶的可溶性催化结构域可切割前明胶酶A的前肽并启动自身蛋白水解激活。受金属蛋白酶组织抑制因子-2(TIMP-2)和金属蛋白酶组织抑制因子-3(TIMP-3)调控。
J Biol Chem. 1996 Jul 19;271(29):17119-23. doi: 10.1074/jbc.271.29.17119.
7
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.人原胶原酶-3(基质金属蛋白酶-13)激活的细胞机制。有证据表明膜型基质金属蛋白酶-1(基质金属蛋白酶-14)和明胶酶A(基质金属蛋白酶-2)能够产生活性酶。
J Biol Chem. 1996 Jul 19;271(29):17124-31. doi: 10.1074/jbc.271.29.17124.
8
Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.凝血酶对前(基质金属蛋白酶-2)(pro-MMP-2)的激活在人脐静脉内皮细胞中是膜型基质金属蛋白酶依赖性的,并产生一种独特的63 kDa活性形式。
Biochem J. 2001 Jul 1;357(Pt 1):107-15. doi: 10.1042/0264-6021:3570107.
9
Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in Furin-Negative Colon Carcinoma LoVo Cells.在弗林蛋白酶阴性的结肠癌细胞LoVo中,整合素原的成熟伴随着MT1-MMP的快速运输和加工。
Traffic. 2004 Aug;5(8):627-41. doi: 10.1111/j.1600-0854.2004.00206.x.
10
Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.实验性深静脉血栓形成和凝血酶对基质金属蛋白酶-2和膜型-1基质金属蛋白酶的差异转录激活作用
J Vasc Surg. 2005 Sep;42(3):539-45. doi: 10.1016/j.jvs.2005.04.051.

引用本文的文献

1
Extracellular molecules in hematopoietic stem cell mobilisation.造血干细胞动员中的细胞外分子。
Int J Hematol. 2017 Feb;105(2):118-128. doi: 10.1007/s12185-016-2123-y. Epub 2016 Nov 8.
2
The In Vitro and In Vivo Response to MMP-Sensitive Poly(Ethylene Glycol) Hydrogels.对基质金属蛋白酶敏感的聚乙二醇水凝胶的体外和体内反应
Ann Biomed Eng. 2016 Jun;44(6):1959-69. doi: 10.1007/s10439-016-1608-4. Epub 2016 Apr 14.
3
Cross-talk between NADPH oxidase-PKCα-p(38)MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells.肺动脉平滑肌细胞中NADPH氧化酶-PKCα-p(38)丝裂原活化蛋白激酶与NF-κB-MT1MMP之间的相互作用在ET-1激活前基质金属蛋白酶-2中的作用
Mol Cell Biochem. 2016 Apr;415(1-2):13-28. doi: 10.1007/s11010-016-2673-6. Epub 2016 Feb 24.
4
Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets.血小板内皮细胞四跨膜蛋白需要唾液酸化的O-聚糖以在淋巴管内皮细胞上稳定表达并与血小板相互作用。
Blood. 2014 Dec 4;124(24):3656-65. doi: 10.1182/blood-2014-04-572107. Epub 2014 Oct 21.
5
Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation.基质金属蛋白酶-2(MMP-2)的二聚化:对 MMP-2 激活的功能意义。
J Biol Chem. 2012 Jun 29;287(27):22643-53. doi: 10.1074/jbc.M111.337949. Epub 2012 May 10.
6
Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.乳腺癌细胞和成骨细胞共培养的微阵列和蛋白质组学分析:成骨细胞基质金属蛋白酶(MMP)-13 在骨转移中的作用。
J Biol Chem. 2011 Sep 30;286(39):34271-85. doi: 10.1074/jbc.M111.222513. Epub 2011 Jul 22.
7
Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.凝血酶依赖性 MMP-2 活性受肝素硫酸酯调节。
J Biol Chem. 2010 Dec 31;285(53):41270-9. doi: 10.1074/jbc.M110.171595. Epub 2010 Nov 1.
8
Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth.PTGER3 和 PON1 基因与早产的母婴遗传关联。
PLoS One. 2010 Feb 3;5(2):e9040. doi: 10.1371/journal.pone.0009040.
9
Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology.同型半胱氨酸介导的血管病理生物学中的血栓形成与血管生成抑制
J Clin Invest. 2009 Nov;119(11):3203-5. doi: 10.1172/JCI40924. Epub 2009 Oct 19.

本文引用的文献

1
Activation of cartilage matrix metalloproteinases by activated protein C.活化蛋白C对软骨基质金属蛋白酶的激活作用。
Arthritis Rheum. 2009 Mar;60(3):780-91. doi: 10.1002/art.24303.
2
Thrombin stimulates mitogenesis in pig cerebrovascular smooth muscle cells involving activation of pro-matrix metalloproteinase-2.凝血酶通过激活基质金属蛋白酶原-2刺激猪脑血管平滑肌细胞的有丝分裂。
Neurosci Lett. 2009 Feb 27;451(3):199-203. doi: 10.1016/j.neulet.2009.01.003. Epub 2009 Jan 8.
3
Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo.蛋白酶激活受体1的激活对于体内单核细胞趋化蛋白1依赖性白细胞募集是必要的。
J Exp Med. 2008 Aug 4;205(8):1739-46. doi: 10.1084/jem.20071427. Epub 2008 Jul 7.
4
Control of matrix metalloproteinase catalytic activity.基质金属蛋白酶催化活性的调控
Matrix Biol. 2007 Oct;26(8):587-96. doi: 10.1016/j.matbio.2007.07.001. Epub 2007 Jul 7.
5
Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells.骨髓间充质干细胞趋化因子的综合分析
Stem Cells Dev. 2007 Feb;16(1):119-29. doi: 10.1089/scd.2006.0032.
6
Collagen I and thrombin activate MMP-2 by MMP-14-dependent and -independent pathways: implications for airway smooth muscle migration.胶原蛋白I和凝血酶通过依赖MMP-14和不依赖MMP-14的途径激活MMP-2:对气道平滑肌迁移的影响。
Am J Physiol Lung Cell Mol Physiol. 2007 Apr;292(4):L1030-8. doi: 10.1152/ajplung.00317.2006. Epub 2006 Dec 22.
7
Individual Timp deficiencies differentially impact pro-MMP-2 activation.个体组织金属蛋白酶抑制因子(TIMP)缺陷对前基质金属蛋白酶-2(pro-MMP-2)的激活有不同影响。
J Biol Chem. 2006 Apr 14;281(15):10337-46. doi: 10.1074/jbc.M512009200. Epub 2006 Feb 9.
8
Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
J Biol Chem. 2005 Mar 25;280(12):10974-80. doi: 10.1074/jbc.M412370200. Epub 2005 Jan 6.
9
A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2.肥大细胞糜蛋白酶在促基质金属蛋白酶-9和促基质金属蛋白酶-2激活中的关键作用。
J Biol Chem. 2005 Mar 11;280(10):9291-6. doi: 10.1074/jbc.M410396200. Epub 2004 Dec 22.
10
CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer.CXCR3标记能够穿越人脑微血管内皮细胞层的CD4+记忆性T淋巴细胞。
J Neuroimmunol. 2004 Aug;153(1-2):150-7. doi: 10.1016/j.jneuroim.2004.05.004.